Pharmaceutical compositions

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/70 (2006.01) A61P 3/10 (2006.01)

Patent

CA 2755392

A pharmaceutical composition comprising a combination of (A) a 1-thio-D- glucitol compound represented by the general formula (I) and (B) at least one member of the group consisting of biguanides, insulin secretagogues, insulin sensitizers, insulins, dipeptidyl peptidase IV inhibitors, .alpha.-glucosidase inhibitors, and GLP-1 mimetics, has superior efficacy in preventing or treating diabetes mellitus, diseases associated with diabetes mellitus, or complications of diabetes mellitus and yet it causes no ap-preciable side effects.

L'invention porte sur une composition pharmaceutique comprenant une combinaison de (A) un composé 1-thio-D-glucitol représenté par la formule générale (I) et (B) au moins un élément du groupe constitué par les biguanides, les sécrétagogues de l'insuline, les agents de sensibilisation à l'insuline, les insulines, les inhibiteurs de dipeptidyl peptidase IV, les inhibiteurs d'a-glucosidase et les mimétiques de GLP-1. La composition pharmaceutique a une efficacité supérieure pour la prévention ou le traitement du diabète sucré, de maladies associées au diabète sucré, ou de complications du diabète sucré, mais n'a cependant pas d'effets secondaires à signaler.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1608805

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.